DrugsControl Media Services
DrugsControl.org

News Detail

USFDA pulls up Jagsonpal Pharma for manufacturing lapses Bhiwadi API plant (24-02-2025)

New Delhi, 24 Feb 2025: The US health regulator has pulled up Jagsonpal Pharmaceuticals for significant manufacturing lapses at its Rajasthan-based active pharmaceutical ingredients (APIs) plant.

In a warning letter issued to the company's Managing Director Manish Gupt......
View Details

Source : PTI
Jagsonpal Pharma Jagsonpal Pharmaceuticals USFDA manufacturing lapses

Related News